APA (7th ed.) Citation

Farrell, R., Burling, M., Lee, Y. C., Pather, S., Robledo, K., Mercieca-Bebber, R., & Stockler, M. (2022). Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer (ANZGOG1901/2020). Journal of Gynecologic Oncology, 33(1), 1. https://doi.org/10.3802/jgo.2022.33.e1

Chicago Style (17th ed.) Citation

Farrell, Rhonda, Michael Burling, Yeh Chen Lee, Selvan Pather, Kristy Robledo, Rebecca Mercieca-Bebber, and Martin Stockler. "Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic Intraperitoneal Chemotherapy Following Interval Cytoreductive Surgery for Stage III Epithelial OVArian, Fallopian Tube and Primary Peritoneal Cancer (ANZGOG1901/2020)." Journal of Gynecologic Oncology 33, no. 1 (2022): 1. https://doi.org/10.3802/jgo.2022.33.e1.

MLA (9th ed.) Citation

Farrell, Rhonda, et al. "Clinical Trial Protocol for HyNOVA: Hyperthermic and Normothermic Intraperitoneal Chemotherapy Following Interval Cytoreductive Surgery for Stage III Epithelial OVArian, Fallopian Tube and Primary Peritoneal Cancer (ANZGOG1901/2020)." Journal of Gynecologic Oncology, vol. 33, no. 1, 2022, p. 1, https://doi.org/10.3802/jgo.2022.33.e1.